An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 1. Head and neck tumor

Journal of Japan Society for Cancer Therapy

Volumn 20, Issue 5, 1985, Pages 984-993

  Niibe, H ^a   Takahashi, I ^a   Mitsuhashi, N ^a   Miyaishi, K ^b   Itoh, J ^b   Maehara, Y ^b   Nakajima, N ^b   Suto, H ^b   Sakaino, K ^b   Matsuura, S ^b  

^a GUNMA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; PLACEBO;

ABDOMINAL DISCOMFORT; ADVERSE DRUG REACTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG THERAPY; ERYTHEMA; FEVER; GASTROINTESTINAL TOXICITY; HEAD AND NECK CANCER; HUMAN; IATROGENIC DISEASE; INTOXICATION; LARYNX; MOUTH; PHARYNX; PREVENTION; RADIATION PROTECTION; RADIOTHERAPY; RASH; RESPIRATORY SYSTEM; SKIN TOXICITY; THERAPY;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AMIFOSTINE; CARCINOMA, SQUAMOUS CELL; CHILD; CLINICAL TRIALS; DOUBLE-BLIND METHOD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; ORGANOTHIOPHOSPHORUS COMPOUNDS; RADIATION-PROTECTIVE AGENTS;

EID: 0021844084     PISSN: 00214671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)